Biocryst Pharmaceuticals (BCRX) FCF Margin Growth (1y) (2011 - 2026)
Biocryst Pharmaceuticals (BCRX) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 74.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -247.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 546.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -209.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -522.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 828.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 301.00 |
| 10 | Biocryst Pharmaceuticals | 2.27 Bn | 2.20 Bn | 151.04 Mn | -2,099.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,099.00 |
| Dec 31, 2025 | 4.14 Mn |
| Sep 30, 2025 | 1,908.00 |
| Jun 30, 2025 | 2,567.00 |
| Mar 31, 2025 | 3,922.00 |
| Dec 31, 2024 | 420.00 |
| Sep 30, 2024 | 3,073.00 |
| Jun 30, 2024 | 2,234.00 |
| Mar 31, 2024 | 1,119.00 |
| Dec 31, 2023 | 2,282.00 |
| Sep 30, 2023 | 1,894.00 |
| Jun 30, 2023 | 1,936.00 |
| Mar 31, 2023 | 8,734.00 |
| Dec 31, 2022 | 4,054.00 |
| Sep 30, 2022 | 1,465.00 |
| Jun 30, 2022 | 976.00 |
| Mar 31, 2022 | 16,398.00 |
| Dec 31, 2021 | 99,172.00 |
| Sep 30, 2021 | 57,207.00 |
| Jun 30, 2021 | 103,117.00 |